At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Radical Image-Guided Radiotherapy (radiation)
- How long the study runs
- Study runs about 100 months (dates as stated)
- About the drug or intervention
- Radical Image-Guided Radiotherapy — radiation: Questionnaires administered will monitor the clinical toxicity experienced by each patient up to 5 years post radiotherapy
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 310
- Started
- 2019-09-11
- Last checked
- 2021-07
Plain English Summary
What is this study?
- • Testing a new treatment for cancer
- • Clinical study - 310 participants
- • The Hamlet
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with cancer
Where?
- • Cambridge - Cambridge University Hospitals NHS Foundation Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The Hamlet.rt study is a prospective data collection and patient questionnaire study for patients undergoing image-guided radiotherapy with curative intent. The aim of the study is to use novel machine learning and mathematical techniques to build a model that can predict the risk of significant side effects from radiotherapy treatment for an individual patient: using calculations of normal tissue dose from radiotherapy treatment planning and patient baseline characteristics derived from image and non-image data, continuously updated as the patient is reviewed both during and after treatment. A secondary goal of the project is to facilitate research in machine learning and medical image processing for radiation therapy through the creation of a discoverable and shared data resource for research use.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
- How fit you need to be: ECOG 0 or better
What the study is looking for
- ✓Participant is willing and able to give agreement to take part for participation in the study
- ✓Male or Female
- ✓Aged 18 years or older
- ✓Diagnosed with primary prostate cancer, head and neck cancer, lung cancer, or brain tumour
- ✓Treated with curative intent
Who cannot take part
- ✗Participant is not willing or able to complete the protocol-stated requirements of the study, e.g. accessing \&...
See the full criteria
Where Is This Study? (1 UK site)
Cambridge University Hospitals NHS Foundation Trust
Cambridge CB2 0QQ, United Kingdom
How to Get in Touch
Meena Murthy
Sponsor contactCONTACT
CCTU Cancer
Sponsor contactCONTACT